Addyi for Menopause: FDA Expands Desire Pill Access
FDA Broadens Approval of Addyi for Women Experiencing Sexual Desire Issues After Menopause The Food and Drug Administration (FDA) has expanded the approved use of Addyi (flibanserin), a medication designed to treat hypoactive sexual desire disorder (HSDD) in women, now including those who have completed menopause. This decision offers a potential new option for women … Read more